TERC rs10936599 — The Telomere Length Paradox at 3q26
Telomeres — the repetitive DNA caps that protect chromosome ends — shorten with every cell
division, acting as a biological clock that marks cellular age. The gene TERC encodes the
RNA template that the telomerase enzyme uses to rebuild these caps, and the chromosomal
region 3q26.2 harboring TERC contains some of the strongest genetic determinants of
telomere length discovered through population genetics.
rs10936599 is a regulatory variant near TERC that emerged as the single most significant
predictor of leukocyte telomere length in the landmark 2013 genome-wide meta-analysis by
Codd and colleagues. Its biology illustrates a striking paradox at the heart of telomere
science: the allele that maintains longer telomeres also increases the risk of certain
cancers, while the allele linked to shorter telomeres — and accelerated cellular aging —
appears to reduce cancer susceptibility.
The Mechanism
rs10936599 sits approximately near the 5'UTR region of TERC in an area that influences
how much TERC RNA the cell produces or how stable that RNA is. TERC does not encode
a protein — it is the RNA template that TERT (the protein catalytic component) uses to
add the TTAGGG repeat sequence back to shortening telomere ends.
The C allele (major, ~75% frequency) is associated with higher TERC mRNA levels and
longer telomeres — approximately 117 base pairs more per allele | from the ENGAGE consortium
data in Codd et al. 2013. The T allele (minor,
~25% frequency) appears to reduce TERC expression or activity, resulting in less efficient
telomere rebuilding and telomeres that are measurably shorter over a lifetime.
The paradox arises because longer telomeres suppress cellular senescence — the process that
normally kills precancerous cells before they can proliferate. Cells with genetically longer
telomeres can divide more times before entering senescence, which is protective against
age-related organ failure but removes one of the body's natural cancer checkpoints. This
is why the C allele (longer telomere) appears in GWAS findings for colorectal cancer,
glioma, lung cancer, and multiple sclerosis susceptibility, while the T allele (shorter
telomere) increases risk for cardiovascular disease and COPD — diseases driven by
premature cellular exhaustion rather than unchecked proliferation.
The Evidence
The definitive characterization of rs10936599 came from a
genome-wide meta-analysis of 37,684 individuals with replication in 10,739 more | Codd V
et al. Identification of seven loci affecting mean telomere length. Nat Genet 2013.
The T allele was the strongest single-SNP predictor of shorter telomeres in the entire
genome (beta = −0.097, P = 2.54×10⁻³¹), explaining 0.36% of variance in leukocyte telomere
length — equivalent to approximately 3.9 years of age-related telomere attrition per T allele.
The same meta-analysis identified rs10936599 as part of a seven-SNP genetic risk score (GRS)
for telomere length — a tool now widely used in Mendelian randomization studies to tease
apart the causal effects of telomere length from confounders. rs10936599 contributes the
largest single weight in this GRS, making it the anchor SNP for genetically determined
telomere length in population genetics research.
The earlier
2010 GWAS in 12,409 individuals | Codd V et al. Common variants near TERC are associated
with mean telomere length. Nat Genet 2010
first established the TERC 3q26 locus as the top genetic determinant of leukocyte telomere
length, and rs10936599 tags the strongest signal within this locus.
For cardiovascular health, a
prospective study of acute heart failure patients | Chen et al. Frontiers in Endocrinology
2021 found that rs10936599 genotype was an
independent predictor of 18-month mortality. In the dominant model (CC+CT vs TT), mutant
allele carriers had HR 2.84 (95% CI 1.48–5.44, P = 0.001) for death — a clinically
significant prognostic effect in patients with established heart disease.
A
case-control study in Chinese Han individuals | Li et al. Scientific Reports 2017
found that the C allele at rs10936599 was associated with increased ischemic stroke risk
(OR = 1.26, 95% CI 1.00–1.58, P = 0.049). This finding, where the longer-telomere C allele
increases stroke risk, reflects the complex pleiotropic effects of telomere length on
vascular biology that vary by context, age, and disease stage.
The Longevity-Aging Framing
In the longevity-aging context, the T allele is the primary concern: it reduces telomere
maintenance capacity, accelerating the rate at which cells accumulate telomere damage and
enter senescence. Each T allele is equivalent to approximately 3.9 years of extra biological
aging at the telomere level. TT homozygotes — carrying two T alleles — have telomeres
genetically comparable to someone nearly 8 years older.
Critically, the T allele interacts with lifestyle factors that independently shorten
telomeres: smoking, chronic inflammation, psychological stress, and oxidative load. For
carriers of the T allele, these environmental insults deplete an already smaller telomere
reserve.
The C allele (normal for longevity purposes) does carry its own complex biology — the
longer-telomere state mildly increases risk for some cancers by reducing cellular senescence
as a tumor-suppressive mechanism. This is worth knowing but is a very different clinical
concern from accelerated aging.
Interactions
rs10936599 is part of the TERC 3q26.2 locus that also harbors rs12696304 and rs16847897,
two other variants associated with telomere length. These SNPs are not in tight linkage
disequilibrium and may tag partially independent regulatory effects on TERC expression.
Individuals carrying the T allele at rs10936599 alongside risk alleles at rs12696304 (G)
or rs16847897 (C) may have compounded reduction in telomere maintenance from the TERC locus.
At the pathway level, rs10936599 interacts with TERT rs2736100 (the catalytic protein
component of telomerase). Both TERC and TERT must function adequately for telomere
maintenance; individuals with reduced function at both loci face the most pronounced
telomere attrition.
rs10936599 is included in the standard seven-SNP Mendelian randomization genetic instrument
for telomere length alongside rs2736100, rs7675998, rs9420907, rs8105767, rs755017, and
rs11125529 — reflecting its role as the dominant genetic determinant of leukocyte telomere
length in the genome.
All genotypes
Two copies of the common allele associated with longer telomeres and standard cellular aging trajectory
You carry two copies of the C allele at rs10936599, the genotype associated with the longest telomere length at this locus. The C allele is linked to higher TERC expression, greater telomerase activity, and telomeres that maintain their length more effectively across cell divisions. This is the most common genotype globally, present in approximately 56% of people by Hardy-Weinberg frequency from the ~75% C allele frequency. From a cellular aging standpoint, the CC genotype is favorable — your telomere maintenance capacity at this locus is at the higher end of normal variation, and you are not at genetically elevated risk for telomere-driven accelerated aging from this variant. The C allele does carry a mild, context-dependent association with slightly higher risk for certain cancers (colorectal, glioma) due to reduced cellular senescence, and may contribute to ischemic stroke susceptibility in some populations. These effects are small and operate through the same long-telomere biology that protects against aging.
One short-telomere allele with mild reduction in TERC-mediated maintenance — roughly equivalent to 3–4 years of additional cellular aging
You carry one copy of each allele: the C allele (longer telomeres) and the T allele (shorter telomeres). The additive effect model for rs10936599 means one T allele reduces relative telomere length by approximately 0.097 T/S ratio units — equivalent to roughly 3.9 years of age-related telomere attrition from this variant alone. About 38% of people share this heterozygous genotype based on the ~75% C allele frequency globally. This intermediate genotype places you modestly below average for genetically determined telomere length at the TERC locus. The effect is real but not severe — it means your telomere reserve is slightly smaller than CC carriers', and you have less buffer against the environmental and lifestyle factors that accelerate telomere shortening.
Two copies of the shorter-telomere allele — genetically equivalent to approximately 7–8 years of additional cellular aging at the TERC locus
You carry two copies of the T allele at rs10936599, the genotype associated with the shortest telomeres at this locus. Each T allele reduces relative telomere length by approximately 0.097 T/S ratio units — two copies together produce a reduction equivalent to approximately 7–8 years of additional age-related telomere attrition compared to CC carriers. The TT genotype is uncommon, affecting roughly 6% of people based on the ~25% T allele frequency globally. In the Codd et al. 2013 meta-analysis of 37,684 individuals, rs10936599 was the most significant single-SNP predictor of leukocyte telomere length in the human genome — and the TT genotype represents the extreme short-telomere end of this dominant genetic signal. This genotype contributes the largest per-SNP weight in the standard seven-SNP telomere length genetic risk score used in population studies.